Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal white petrolatum or chlorhexidine to reduce postoperative wound infections in dermatologic surgery
ACTRN12612001051831Phase 2Recruiting
- Sponsor
- Eugene Tan
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of petrolatum, chlorhexidine and Normal Saline-Benha University in surgical site infection (SSI) and staphylococcal carrier state (3 arms), sponsored by Eugene Tan. Primary endpoint: Incidence of postoperative wound infection. Started Sep 2013; status: recruiting.
02
Drugs
petrolatumchlorhexidineNormal Saline-Benha University
03
Conditions
surgical site infection (SSI)staphylococcal carrier state
Beyond the preview
Go deeper on ACTRN12612001051831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001051831.